Amgen is a biopharmaceutical company based in Thousand Oaks, California, that develops and sells biological medicines. It last closed at $435.64 on Nov 20, down 0.72% on the day. The next earnings report for AMGN is expected around Tue, Feb 2, 2027, after the close. For the quarter ended Sep 2026, AMGN reported EPS of $7.08 on revenue of $10.37B, with revenue up 8.5% from a year ago. Over its last 8 reports the stock moved an average of 5.2% the session after earnings. Over the last 12 months AMGN insiders bought $0 of stock on the open market and sold $26.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is AMGN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AMGN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AMGNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AMGN · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is 12% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $431.60, and the nearest resistance the Pivot at $438.55.
Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 2.7%/day
Key levels
$483.9952 week high+11.1%
$458.3520 day average+5.2%
$442.58Pivot R1+1.6%
$441.76Swing high (Oct 15)+1.4%
$438.55Pivot+0.7%
$435.64Last close
$431.60Pivot S1−0.9%
$430.4550 day average−1.2%
$426.00Swing low (Aug 31)−2.2%
$414.77100 day average−4.8%
$383.40200 day average−12.0%
$312.3852 week low−28.3%
Indicators
RSI (14)
41.02
Middle of its range
Neutral
MACD
3.51
Below its signal line
Bearish
Stochastic
5.0
Near the bottom of its range
Oversold
ADX (14)
29.4
Trending down
Williams %R
-97.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-147.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.4%
Change over 10 sessions
Bearish
ATR (14)
$11.58
Typical daily range, 2.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 6.1%/day
Key levels
$483.9952 week high+11.1%
$458.3520 day average+5.2%
$442.58Pivot R1+1.6%
$441.76Swing high (Oct 15)+1.4%
$438.55Pivot+0.7%
$435.64Last close
$431.60Pivot S1−0.9%
$430.4550 day average−1.2%
$426.00Swing low (Aug 31)−2.2%
$414.77100 day average−4.8%
$383.40200 day average−12.0%
$312.3852 week low−28.3%
Indicators
RSI (14)
57.33
Middle of its range
Neutral
MACD
23.87
Above its signal line
Bullish
Stochastic
72.5
Middle of its range
Neutral
ADX (14)
29.6
Trending up
Williams %R
-44.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
81.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+15.4%
Change over 10 sessions
Bullish
ATR (14)
$26.76
Typical daily range, 6.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AMGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AMGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AMGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AMGNHow many large options trades hit AMGN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AMGN in the last 90 days.
From SEC Form 4 filings by AMGN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AMGN is in one of them and how their past AMGN trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Amgen
Amgen is a biopharmaceutical company based in Thousand Oaks, California. It develops and sells biological products, which are medicines made from biological sources rather than diagnostic substances. Its medicines are used by patients and the healthcare providers who treat them. The company is a multinational business with operations in several countries.